Ganeden Receives FDA GRAS on Probiotic-Derived Immune Health Ingredient: Staimune

Food and Healthcare Press Releases Thursday June 8, 2017 12:32
CLEVELAND--8 Jun--PRNewswire/InfoQuest
New patented offering expands immunity formulations in functional foods and beverages

Ganeden, already known as a leader in probiotic technology, has used its patented probiotic strain to develop an immune health ingredient: Staimune(TM). The new ingredient utilizes the cells of the probiotic GanedenBC30(R) to support immune health, at cost effective inclusion levels. Available later this summer, Ganeden anticipates Staimune to be an industry-changing development.

Officially identified as "Inactivated Bacillus coagulans GBI-30, 6086", Staimune's ease of formulation opens up new opportunities in functional foods and beverages—most importantly in shelf-stable beverages and high-water-activity products. Staimune is FDA GRAS, non-GMO, organic compliant and kosher, making it extremely accessible for use in a vast amount of applications.

Multiple peer-reviewed and published studies show the immune health benefits of GanedenBC30 cells, with additional in-vitro and human clinical studies on Staimune currently underway.

"After seeing the impressive immune supporting benefits of GanedenBC30, we decided to dive further into the mechanism of action," said Michael Bush, president and CEO of Ganeden. "We discovered and ultimately patented this novel ingredient which provides the opportunity to share the immune benefits of the probiotic in product formats that do not support the use of the live organism."

Staimune provides the option for manufacturers that want to focus specifically on immune health, and for those with processes that cause formulation challenges for live probiotics. With an inclusion rate of just 50mg, Staimune does not alter the flavor or texture profiles of finished goods, allowing for easy application into a large number of product categories.

Staimune will be available for formulation starting in the summer of 2017. For more information on the immune health ingredient and Ganeden's other probiotic technologies, visit GanedenProbiotics.com.
About Ganeden:

Ganeden(R) is at the forefront of probiotic research and product development with an extensive library of published studies and more than 135 patents for probiotic technologies in the supplement, food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30(R) its patented, FDA GRAS and highly stable probiotic ingredient. Through the fermentation process of GanedenBC30, Ganeden developed Bonicel(R), the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. Ganeden's newest ingredient, Staimune(TM) is a patented probiotic technology comprising of inactivated GanedenBC30 cells, which have immune benefits. For more information about Ganeden and licensing opportunities, visit GanedenProbiotics.com.

Logo - https://mma.prnewswire.com/media/458885/Ganeden_Logo.jpg
Logo - https://mma.prnewswire.com/media/520839/Staimune_Logo.jpg

Latest Press Release

Pulsus Healthtech meetings and digital media coalition helping physicians# continued medical education

Pulsus Group is committed to working with medical societies and policymakers to improve the global healthcare education through its global medical and scientific conferences. With a legacy of 30 years of excellence in medical publishing and support from...

Avnet and MedIoTek to Transform Healthcare Delivery in India

Avnet (NYSE: AVT ), a leading global technology distributor, and MedIoTek Health Systems, announce a joint marketing agreement to promote MedIoTek's VinCense remote patient monitoring system. Under the agreement, Avnet will engage its broad network of...

Lancer Skincare Partners With Apotheca Beauty for Expansion Into the Luxury Middle East Market

Once a closely guarded secret of the Hollywood elite including Victoria Beckham and Kim Kardashian, Lancer Skincare continues to expand its international retail footprint by partnering with Apotheca Beauty. A specialist and privately held distributor in...

Transformation of Conventional Publication Models into Digital Scientific Publishing: A Remarkable Paradigm Shift in Publishing Industry

- OMICS International Open access journals gaining more popularity and Open access week celebrating from October 23-29, 2017 As of October 2017, there are 11,000 Open access journals publishing 2,322,691 articles annually, as per Google Scholar is...

Biochemists Discover Olive Oil Link to Assist Diabetes and Weight Loss

For Thailand's 19 million overweight nationals, and four million diabetes sufferers[1], new scientific evidence shows how the consumption of Olive oil can assist in both weight loss and diabetes management. With diabetes and obesity on the rise in...

Related Topics